SCHEMBL30404232

SCHEMBL30404232

CCCCOc1ccc(N2C(=O)c3ccc4c5c(ccc(c35)C2=O)C(=O)N(c2ccc(OCCCC)cc2)C4=O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.50
APAF1 O14727 1/20 0.50
CYP2D6 P10635 4/20 0.49
CYP2C9 P11712 4/20 0.49
PABPC1 P11940 1/20 0.49
CYP1A2 P05177 4/20 0.49
CYP2C19 P33261 4/20 0.49
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
HPGD P15428 1/20 0.49
PPARG P37231 1/20 0.48
CACNA1B Q00975 1/20 0.46
APBA1 Q02410 1/20 0.46
LMNA P02545 2/20 0.45
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12732202 0.83 TDP1 (0.59) POLBCYP2D6CYP2C9KDM4EALDH1A1
SCHEMBL17514374 0.82 HTT (0.39) POLBCYP2D6CYP2C9KDM4EALDH1A1
SCHEMBL3408128 0.81 CYP2D6 (0.57) POLBAPAF1CYP2D6CYP2C9CYP1A2
SCHEMBL29353556 0.81 CYP2D6 (0.57) POLBAPAF1CYP2D6CYP2C9CYP1A2
SCHEMBL17514371 0.81 KMT2A (0.39) CYP2D6CYP2C9PABPC1ALDH1A1PPARG
SCHEMBL17514429 0.81 METAP2 (0.40) POLBCYP2D6CYP2C9KDM4EALDH1A1
SCHEMBL10584174 0.81 KDM4E (0.59) POLBCYP2D6CYP2C9KDM4EALDH1A1
SCHEMBL12189563 0.80 CA9 (0.47) PABPC1LMNAHTTSMN1; SMN2CA12
SCHEMBL17514419 0.80 HTT (0.37) PABPC1KDM4EALDH1A1HPGDLMNA
SCHEMBL17514361 0.79 HTT (0.37) PABPC1KDM4EALDH1A1HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4644331-A2 POSITIVE ELECTRODE AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2025-11-05 EP disclosed
US-12406503-B2 Method and apparatus for the detection of behaviours in a retail environment EVERSEEN LIMITED (IE) 2025-09-02 US disclosed
US-20240243327-A1 NAPHTHALENE DIIMIDE COMPOUND AND REDOX FLOW BATTERY CONTAINING THE SAME KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2024-07-18 US disclosed
US-20240144689-A1 METHOD AND APPARATUS FOR THE DETECTION OF BEHAVIOURS IN A RETAIL ENVIRONMENT EVERSEEN LIMITED (IE) 2024-05-02 US disclosed
US-11874606-B2 System and method for controlling measurements of sample's parameters NOVA LTD. (IL) 2024-01-16 US disclosed
CN-116284819-A N, N' -bis (glycyl) naphthalimide coordination polymer and preparation and application thereof 华南师范大学 2023-06-23 CN disclosed
US-20230185203-A1 System and method for controlling measurements of sample's parameters NOVA LTD. (IL) 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240243327-A1 NAPHTHALENE DIIMIDE COMPOUND AND REDOX FLOW BATTERY CONTAINING THE SAME IDH2, NDUFV2, NDUFS8 POLB 1021/4885APAF1 1915/4885CYP2D6 1122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.